U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Psychopharmacologic Drugs Advisory Committee
  6. Psychopharmacologic Drugs Advisory Committee Roster
  1. Psychopharmacologic Drugs Advisory Committee

Psychopharmacologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies = 1
The committee consists of a core of 9 voting members.

Chairperson
Rajesh Narendran, MD
Expertise: Psychiatry
Term: 8/25/2021 - 6/30/2025
Attending Psychiatrist
Resolve Crisis Services
UPMC Western Psychiatric Hospital
Professor in Radiology and Psychiatry
University of Pittsburgh School of Medicine
Psychiatric Molecular Imaging Program
200 Lothrop Street
University of Pittsburgh
Pittsburgh, Pennsylvania 15213

Designated Federal Officer
Joyce Frimpong, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: PDAC@fda.hhs.gov

+ Michelle Baladi, PhD
Expertise: Neuropsychiatry
Term: 2/15/2024 – 10/31/2027
Executive Director, Clinical Development Neuroscience
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, California, 94304

**Carla M. Canuso, MD
Expertise: Neuropsychiatry
Term: 2/15/2024 –10/31/2027
Vice President, Head of Neuropsychiatry Clinical Development
Janssen Research and Development, LLC
1125 Trenton-Harbourton Road
Titusville, New Jersey, 08560

Walter S. Dunn, MD, PhD
Expertise: Psychiatry
Term: 8/25/2021 – 6/30/2025
Assistant Clinical Professor
University of California Los Angeles
Department of Psychiatry
Director, Mood Disorders Section
Director, Interventional Psychiatry Service
West Los Angeles Veterans Affairs Medical Center
11301 Wilshire Boulevard
Los Angeles, California 90073

Jess G. Fiedorowicz, MD, PhD
Expertise: Psychiatry
Term: 8/25/2021 -6/30/2025
Head and Chief, Department of Mental Health
The Ottawa Hospital
Professor and Senior Research Chair in Adult Psychiatry, Department of Psychiatry
University of Ottawa
501 Smyth Road
Ottawa, Ontario K1H 8L6

 

Patrick S. Thomas, Jr., MD, PhD
Expertise: Psychiatry
Term: 8/30/2022 – 6/30/2026
Assistant Professor
Department of Psychiatry
Baylor College of Medicine, Menninger Clinic
12301 S. Main Street
Houston, Texas 77035

*Consumer Representative (vacant)
** Industry Representative (non-voting)
+ Alternative Industry Representative (non-voting)

Back to Top